REVIEW
SA JOURNAL OF DIABETES & VASCULAR DISEASE
86
VOLUME 11 NUMBER 2 • JUNE 2014
38. Manschot SM, Brands AM, van der GJ, Kessels RP, Algra A, Kappelle LJ, Biessels
GJ. Brain magnetic resonance imaging correlates of impaired cognition in patients
with type 2 diabetes.
Diabetes
2006;
55
: 1106–1113.
39. Espeland MA, Bryan RN, Goveas JS, Robinson JG, Siddiqui MS, Liu S,
et al
;
WHIMS-MRI Study Group. Influence of type 2 diabetes on brain volumes and
changes in brain volumes: results from the Women’s Health Initiative magnetic
resonance imaging studies.
Diabetes Care
2013;
36
: 90–97.
40. Brüning JC, Gautam, D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone
W, Müller-Wieland D, Kahn CR. Role of brain insulin receptor in control of body
weight and reproduction.
Science
2000;
289
: 2122–2125.
41. Sucov A, Woolard RH. Ethanol-associated hypoglycemia is uncommon
Acad
Emerg Med
1995;
2
: 185–189.
42. Davis EA, Jones TW. Hypoglycemia in children with diabetes: incidence,
counterregulation and cognitive dysfunction.
J Pediatr Endocrinol Metab
1998;
11
: 177–182.
43. Zammitt NN, Streftaris G, Gibson GJ, Deary IJ, Frier BM. Modeling the consistency
of hypoglycemic symptoms: high variability in diabetes. Additional file 1: Figure
S1. Experimental protocol for R/M Diabetes.
Technol Ther
2011;
13
: 571–578.
44. Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.
Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by
continuous subcutaneous glucose monitoring in children and adolescents with
type 1 diabetes.
Pediatr Diabetes
2007;
8
: 157–162.
45. Perantie DC, Lim A, Wu J, Weaver P, Warren SL, Sadler M, White NH Hershey T.
Effects of prior hypoglycemia and hyperglycemia on cognition in children with
type 1 diabetes mellitus.
Pediatr Diabetes
2008;
9
: 87–95.
46. Bjorgaas M, Gimse R, Vik T, Sand T. Cognitive function in type 1 diabetic children
with and without episodes of severe hypoglycaemia.
Acta Paediatr
1997;
86
:
148–153.
47. Kalimo H, Olsson Y. Effects of severe hypoglycemia on the human brain.
Neuropathological case reports.
Acta Neurol Scand
1980;
62
: 345–356.
48. Auer RN, Hugh J, Cosgrove E, Curry B. Neuropathologic findings in three cases of
profound hypoglycemia.
Clin Neuropathol
1989;
8
: 63–68.
49. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus
and its complications. Part 1: diagnosis and classification of diabetes mellitus
provisional report of a WHO consultation.
Diabet Med
1998;
15
: 539–553.
50. Marfaing-Jallat P, Portha B, Penicaud L. Altered conditioned taste aversion and
glucose utilization in related brain nuclei of diabetic GK rats.
Brain Res Bull
1995;
37
: 639–643.
51. Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term
potentiation and spatial memory in leptin receptor deficient rodents.
Neuroscience
2002;
113
: 607–615.
52. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze
learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats:
effects of insulin treatment.
Brain Res
1998;
800
: 125–135.
53. Baydas G, Nedzvetskii VS, Nerush PA, Kirichenko SV, Yoldas T. Altered expression
of NCAM in hippocampus and cortex may underlie memory and learning deficits
in rats with streptozotocin-induced diabetes mellitus.
Life Sci
2003;
73
: 1907–
1916.
54. Flood JF, Mooradian AD, Morley JE. Characteristics of learning and memory in
streptozocin-induced diabetic mice.
Diabetes
1990;
39
: 1391–1398.
55. Awad N, Gagnon M, Messier C. The relationship between impaired glucose
tolerance, type 2 diabetes, and cognitive function.
J Clin Exp Neuropsychol
2004;
26
: 1044–1080.
56. Mooradian AD, Perryman K, Fitten J, Kavonian GD, Morley JE. Cortical
function in elderly non-insulin dependent diabetic patients: behavioral and
electrophysiological studies.
Arch Intern Med
1988;
148
: 2369–2372.
57. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory
improves with glycemic control in older subjects with non-insulin-dependent
diabetes mellitus.
J Am Geriatr Soc
1993;
41
: 1305–1312.
58. Ryan CM, Williams TM. Effects of insulin-dependent diabetes on learning and
memory efficiency in adults.
J Clin Exp Neuropsychol
1993;
15
: 685–700.
59. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral
function in diabetes mellitus.
Diabetologia
1994;
37
: 643–650.
60. Cukierman T, Gerstein HC, Williamson, JD. Cognitive decline and dementia in
diabetes – systematic overview of prospective observational studies.
Diabetologia
2005;
48
: 2460–2469.
61. Pozzessere G, Valle E, de Crignis S, Cordischi VM, Fattapposta F, Rizzo PA,
et al
.
Abnormalities of cognitive functions in IDDM revealed by P300 event-related
potential analysis. Comparison with short-latency evoked potentials and
psychometric tests.
Diabetes
1991;
40
: 952–958.
62. Kurita A, Mochio S, Isogai Y. Changes in auditory P300 event-related potentials
and brainstem evoked potentials in diabetes mellitus.
Acta Neurol Scand
1995;
92
: 319–323.
63. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH. Evidence for
diabetic encephalopathy.
Diabet Med
1991;
8
: 162–167.
64. Alosco ML, Brickman AM, Spitznagel MB, Griffith EY, Narkhede A, Raz N,
et al
.
The adverse impact of type 2 diabetes on brain volume in heart failure.
J Clin Exp
Neuropsychol
2013;
35
: 309–318.
65. Gold AE, Deary IJ, Jones RW, O’Hare JP, Reckless JPD, Frier BM. Severe deterioration
in cognitive function and personality in five patients with long-standing diabetes:
a complication of diabetes or a consequence of treatment?.
Diabet Med
1994;
11
: 499–505.
66. Den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler
MM. Type 2 diabetes and atrophy of the medial temporal lobe structures.
Diabetologia
2005;
46
: 1604–1610.
67. Taylor VH, MacQueen GM. Cognitive dysfunction associated with metabolic
syndrome.
Obes Rev
2007;
8
: 409–418.
68. Van Exel E, de Craen AJ, Gussekloo J, Houx P, Bootsma-van der Wiel A, Macfarlane
PW, et al. Association between high-density lipoprotein and cognitive impairment
in the oldest old.
Ann Neurol
2002;
51
: 716–721.
69. Henderson VW, Guthrie JR, Dennerstein L. Serum lipids and memory in a
population based cohort of middle age women.
J Neurol Neurosurg Psychiatry
2003;
74
: 1530–1535.
70. Elias PK, Wilson PW, Elias MF, Silbershatz H, D’Agostino RB, Wolf PA, Cupples
LA. NIDDM and blood pressure as risk factors for poor cognitive performance.
Diabetes Care
1997;
20
: 1388–1395.
71. Hassing LB, Hofer SM, Nilsson SE, Berg S, Pedersen NL, McClearn G, Johansson
B. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive
decline: evidence from a longitudinal study.
Age Ageing
2004;
33
: 355–361.
72. Hamed SA, Youssef AH, Elserogy YE, Herdan O, Abd-Elaal RF, Metwaly NA,
Hassan MM, Mohamad HO. Cognitive function in patients with Type 2 Diabetes
Mellitus: Relationship to stress hormone (Cortisol).
J Neurol Neurosci
2013:
4
: 3.
73. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to type 2
diabetes?.
Med Sci Monit
2003;
9
: RA35 – RA9.
74. Bruehl H, Rueger M, Dziobek I, Sweat V, Tirsi A, Javier E,
et al
. Hypothalamic-
pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.
J Clin Endocrinol Metab
2007;
92
: 2439–2445.
75. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of
diabetic complications.
Horm Res
2000;
53
: 53–67.
76. Serbedžija P, Ishii DN. Insulin and insulin-like growth factor prevent brain atrophy
and cognitive impairment in diabetic rats.
Indian J Endocrinol Metab
2012;
16
:
S601–610.
77. Rao AA. Views and opinion on BDNF as a target for diabetic cognitive dysfunction.
Bioinformation
2013;
29
(9): 551–554.
78. Skogseid IM, Nordby HK, Urdal P, Paus E, Lileaas F. Increased serum creatine kinase
BB and neuron-specific enolase following head injury indicates brain damage.
Acta Neurochir
(Wien) 1992;
115
: 106–111.
79. Herrmann M, Ehrenreich H. Brain derived proteins as markers of acute stroke:
their relation to pathophysiology, outcome prediction and neuroprotective drug
monitoring.
Restor Neurol Neurosci
2003;
21
: 177–190.
80. Clarke DW, Mudd L, Boyd FT, Fields M, Raizada MK. Insulin is released from rat
brain neuronal cells in culture.
J Neurochem
1986;
47
: 831–836.
81. Brant AM, Jess TJ, Milligan G, Brown CM, Gould GW. Immunlogical analysis of
glucose transporters expressed in different regionsof the rat brain and central
nervous system.
Biochem Biophys Res Commun
1993;
192
: 1297–1302.
82. Wozniak M, Rydzewski B, Baker P, Raizada MK. The cellular and physiological
actions of insulin in the central nervous system.
Neurochem Int
1993;
22
: 1–40.
83. Hopkins DF, Williams G. Insulin receptors are widely distributed in human brain
and bind human and porcine insulin with equal affinity.
Diabet Med
1997;
14
:
1044–1050.
84. Chiu S, Chen C, Cline H. Insulin receptor signaling regulates synapse number,
dendritic plasticity, and circuit function in vivo.
Neuron
2008;
58
: 708–719.
85. Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ,
et al
.
Hyperinsulinemia provokes synchronous increases in central inflammation and
β
-amyloid in normal adults.
Arch Neurol
2005;
62
: 1539–1544.
86. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-
degrading enzyme regulates the levels of insulin, amyloid
β
-protein, and the
β
-amyloid precursor protein intracellular domain in vivo.
Proc Natl Acad Sci USA
2003;
100
: 4162–4167.
87. Young SE, Mainous AG 3rd, Carnemolla M. Hyperinsulinemia and cognitive
decline in a middle-aged cohort.
Diabetes Care
2006;
29
: 2688–2693.
88. Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ. An update on type 2 diabetes,
vascular dementia and Alzheimer’s disease.
Exp Gerontol
2012; 47: 858–864.
89. Alafuzoff I, Aho L, Helisalmi S, Mannermaa A, Soininen H. Beta-amyloid
deposition in brains of subjects with diabetes.
Neuropathol Appl Neurobiol
2008;
35
: 60–68.
Continued on page 94
